282 related articles for article (PubMed ID: 7706731)
1. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
2. Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors.
Nanno M; Seki H; Mathioudakis G; Suzuki R; Itoh K; Ioannides CG; Suzuki S; Chen PF; Platsoucas CD
Eur J Immunol; 1992 Mar; 22(3):679-87. PubMed ID: 1312472
[TBL] [Abstract][Full Text] [Related]
3. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
4. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
5. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas.
Zocchi MR; Ferrarini M; Rugarli C
Eur J Immunol; 1990 Dec; 20(12):2685-9. PubMed ID: 1702723
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.
Kim TY; von Eschenbach AC; Filaccio MD; Hayakawa K; Parkinson DR; Balch CM; Itoh K
Cancer Res; 1990 Sep; 50(17):5263-8. PubMed ID: 2143685
[TBL] [Abstract][Full Text] [Related]
7. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells.
Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL
J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
Karpati RM; Banks SM; Malissen B; Rosenberg SA; Sheard MA; Weber JS; Hodes RJ
J Immunol; 1991 Mar; 146(6):2043-51. PubMed ID: 1672340
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer.
Zocchi MR; Ferrarini M; Migone N; Casorati G
Immunology; 1994 Feb; 81(2):234-9. PubMed ID: 8157272
[TBL] [Abstract][Full Text] [Related]
11. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
12. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
13. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
14. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells.
Orsini DL; van Gils M; Kooy YM; Struyk L; Klein G; van den Elsen P; Koning F
Eur J Immunol; 1994 Dec; 24(12):3199-204. PubMed ID: 7528674
[TBL] [Abstract][Full Text] [Related]
15. Mouse autoreactive gamma/delta T cells. II. Molecular characterization of the T cell receptor.
Ezquerra A; Wilde DB; McConnell TJ; Sturmhöfel K; Valas RB; Shevach EM; Coligan JE
Eur J Immunol; 1992 Feb; 22(2):491-8. PubMed ID: 1311262
[TBL] [Abstract][Full Text] [Related]
16. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor gamma delta repertoire in HIV-1-infected individuals.
Hinz T; Wesch D; Friese K; Reckziegel A; Arden B; Kabelitz D
Eur J Immunol; 1994 Dec; 24(12):3044-9. PubMed ID: 7805732
[TBL] [Abstract][Full Text] [Related]
18. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
19. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.
Fisch P; Oettel K; Fudim N; Surfus JE; Malkovsky M; Sondel PM
J Immunol; 1992 Apr; 148(8):2315-23. PubMed ID: 1532810
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.
Stinissen P; Vandevyver C; Medaer R; Vandegaer L; Nies J; Tuyls L; Hafler DA; Raus J; Zhang J
J Immunol; 1995 May; 154(9):4883-94. PubMed ID: 7722338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
